Kytomaa Harri
Known title: Group Vice PresidentCIK: 0001687174
Associated companies
Transaction History
| EXPO | ▲ Buy | Option Exercise | 4,562 | — | 3/15/2023 | View on chart |
| EXPO | ▼ Sell | Tax Withholding | 1,970 | $204K | 3/15/2023 | View on chart |
| EXPO | ▼ Sell | Open Market | 350 | $36K | 2/24/2023 | View on chart |
| EXPO | ▼ Sell | Open Market | 350 | $38K | 2/17/2023 | View on chart |
| EXPO | ▼ Sell | Open Market | 350 | $37K | 2/15/2023 | View on chart |
| EXPO | ▼ Sell | Open Market | 350 | $37K | 2/13/2023 | View on chart |
| EXPO | ▼ Sell | Open Market | 650 | $67K | 11/18/2022 | View on chart |
| EXPO | ▼ Sell | Open Market | 1,600 | $157K | 8/5/2022 | View on chart |
| EXPO | ▼ Sell | Open Market | 650 | $58K | 5/26/2022 | View on chart |
| EXPO | ▼ Sell | Tax Withholding | 1,686 | $160K | 3/9/2022 | View on chart |
| EXPO | ▲ Buy | Option Exercise | 5,984 | — | 3/9/2022 | View on chart |
| EXPO | ▼ Sell | Open Market | 500 | $62K | 11/12/2021 | View on chart |
| EXPO | ▼ Sell | Open Market | 875 | $100K | 8/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Exponent stock viewed as reasonable versus cash flow value
A recent Yahoo analysis notes that Exponent’s share price appears reasonable when compared with its cash‑flow generation. The view aligns with the company’s current valuation metrics, including a trailing P/E of about 30.6 and a dividend yield of 1.34%. Analysts’ average target price of $84 sits within the recent 52‑week range, suggesting the market’s expectations are consistent with the cash‑flow assessment.
Exponent stock viewed as reasonable versus cash flow value. A recent Yahoo analysis notes that Exponent’s share price appears reasonable when compared with its cash‑flow generation. The view aligns with the company’s current valuation metrics, including a trailing P/E of about 30.6 and a dividend yield of 1.34%. Analysts’ average target price of $84 sits within the recent 52‑week range, suggesting the market’s expectations are consistent with the cash‑flow assessment.